Daniel counsels both established and early-stage companies in a variety of matters, including both buy-side and sell-side transactions, corporate governance issues, and securities law. He works with businesses operating in a range of industries, with a particular focus on the technology and life sciences sectors.
Daniel's practice is primarily concentrated on advising emerging growth companies through various stages of the corporate life cycle, from formation to exit. He has experience representing companies in venture financings, mergers and acquisitions, and going public transactions.
- J.D., University of California - Hastings College of the Law
Magna Cum Laude
UC Hastings Honor Society
- B.A., History, University of Texas
Phi Alpha Theta History Honors Society
My latest insights
DLA Piper advises UpHealth in sale of Cloudbreak Health business for US$180 Million
20 November 2023 .2 minute read